Elocta was associated with better bleed control and fewer injections for hemophilia A patients in a real-world European study ...

Dreieich, Germany, October 29, 2024. Biotest announced today, that it has signed a new distribution agreement with SteinCares, a leading specialty healthcare company in Latin America, for the ...

The global hemophilia treatment market is poised for remarkable growth, with estimates projecting an increase from USD 12.1 billion in 2024 to an impressive USD 18.7 billion by 2034. This substantial ...

Pfizer Inc. has won regulatory approval for its hympavzi drug as a treatment for hemophilia A or B without inhibitors — making it the first antitissue-factor ... for the blood-clotting disorder ...

injection is approved in the U.S. for hemophilia A patients with or without inhibitors, and may be used as an alternative to traditional factor replacement therapies. Hympavzi (marstacimab-hncq) is an ...

South Carolina Dept. of Corrections via AP) COLUMBIA, S.C. (AP) — A condemned South Carolina inmate chose Friday to be executed by lethal injection, instead of by firing squad or electrocution, for ...

Semaglutide is also used in the diabetes treatment Ozempic. Both Wegovy and Mounjaro are given as weekly injections via pre-filled pens that can be self-administered into the upper arm ...

Liam Payne first registered on the pop radar as a fresh-faced 14-year-old, trying out for The X Factor in 2008. "I should really be concentrating on my [school] work but I just think about singing ...

PESHAWAR: Frequent administration of injections was causing “provocative poliomyelitis” as three of the four polio affected children detected so far in the province had paralysis caused by ...

Hympavzi, made by Pfizer, is the first antitissue-factor pathway inhibitor to be approved for the blood-clotting disorder, as well as the first hemophilia drug to offer a once-weekly treatment ...